Use access key #2 to skip to page content.
$20.56 -1.22 (-5.60%)
12/1/2008 2:03 PM

Auxilium Pharmaceuticals, Inc. (AUXL)

CAPS Rating:
*

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

View All Commentary (AUXL)

Recs

0

Avatar greenwave3 (85.58) Submitted: 8/27/08 12:18 AM : Underperform Start Price: $39.79 AUXL Score: 14.62

Nice products, too much hype. How can you justify a market cap of $1.6 Billion with sales of under $100 Million? Some claim 20% annual sales growth. Even assuming they're correct, this one needs to be chopped in half before we even start to think about a fair valuation.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links